Keywords: troubled, drugmaker, cytogen, takes, up, 6m, offer
Troubled US drugmaker Cytogen takes up $22.6M offer from UK's EUSA Pharma
Article | 17 March 2008
The UK headquartered specialty pharmaceutical group EUSA Pharma has entered an agreement to acquire USA-based loss-making oncology drug specialist Cytogen, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
